• Alexion Receives Positive CHMP Opinion for SOLIRIS americanpharmaceuticalreview
    July 29, 2019
    Alexion Pharmaceuticals announced the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to extend the current marketing authorization of SOLIRIS® (eculizumab) to ...
PharmaSources Customer Service